AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
ByAinvest
Monday, Aug 25, 2025 8:04 am ET1min read
Phathom Pharmaceuticals will participate in the Cantor Global Healthcare Conference 2025 and H.C. Wainwright 27th Annual Global Investment Conference in September. Management will participate in 1x1 meetings throughout the conferences and there will be live webcasts. The company markets vonoprazan for various gastrointestinal diseases in the US.
Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, has announced its participation in two upcoming investor conferences in September 2025. The company will present at the Cantor Global Healthcare Conference on September 3 at 9:10 am EDT and the H.C. Wainwright 27th Annual Global Investment Conference on September 8 at 1:00 pm EDT.Management representatives from Phathom Pharmaceuticals will conduct one-on-one meetings throughout both conferences. These events are expected to provide investors with a comprehensive overview of the company's pipeline, current market position, and future growth prospects.
The Cantor Global Healthcare Conference 2025 will take place in New York, NY, from September 3 to 5, 2025. The live webcast for the Phathom Pharmaceuticals presentation is scheduled for September 3 at 9:10 am EDT. The H.C. Wainwright 27th Annual Global Investment Conference will be held in New York, NY, from September 8 to 10, 2025, with the live webcast for Phathom Pharmaceuticals' presentation set for September 8 at 1:00 pm EDT. Both webcasts and archived recordings will be available on the Phathom Pharmaceuticals website for up to 90 days following the events [1].
Phathom Pharmaceuticals markets vonoprazan, a first-in-class potassium-competitive acid blocker (PCAB), for various gastrointestinal conditions including Non-Erosive GERD and H. pylori infection treatment in the United States [2].
References:
[1] https://www.marketscreener.com/news/phathom-pharmaceuticals-to-participate-in-upcoming-investor-conferences-ce7c50d8d889f324
[2] https://www.stocktitan.net/news/PHAT/phathom-pharmaceuticals-to-participate-in-upcoming-investor-nnibl7okihup.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet